Pistorius refuses to look at photo of dead lover

Apr 10, 2014

Pistorius refuses to look at photo of dead lover

A shaken Oscar Pistorius refused to look at a gruesome photo of his slain girlfriend’s bloodied head on Wednesday, telling a prosecutor through tears, “I don’t have to look at a picture. I was there.” “It’s time that you look at it,” chief prosecutor ...

Apr 8, 2014

DHC chairman calls resignation 'impressive' move

Following the resignation Monday of Your Party leader Yoshimi Watanabe amid a scandal involving ¥800 million in loans from major cosmetics company DHC Corp., its chairman, Yoshiaki Yoshida, issued a statement later the same day. “We can say that (Yoshimi Watanabe) has acted in ...

Angry families want GM prosecuted for defects

Apr 7, 2014

Angry families want GM prosecuted for defects

The families of those who died in General Motors cars with defective ignition switches want prosecutors to go after GM insiders responsible for letting the problems fester for more than a decade — and perhaps for covering them up. “The only way the public ...

France snubs Rwanda memorial

Apr 6, 2014

France snubs Rwanda memorial

France has canceled plans to attend a ceremony Monday marking the 20th anniversary of the Rwandan genocide following accusations by Rwandan President Paul Kagame of French involvement in the massacre. The African weekly Jeune Afrique quoted Kagame as denouncing the “direct role of Belgium ...

Twitter still blocked in Turkey despite court order

Apr 3, 2014

Twitter still blocked in Turkey despite court order

Turkey’s government faced growing pressure Thursday to quickly implement a top court order to unblock Twitter, which it had banned after corruption claims went viral on the social media site. Prime Minister Recep Tayyip Erdogan ordered the block on March 20 in the lead-up ...

Apr 3, 2014

Heads roll at Novartis over scandal

Swiss pharmaceutical giant Novartis said Thursday it is replacing the top executives at its Japanese unit over allegations that the division hid the existence of serious potential side effects linked to leukemia treatments from regulators. David Epstein, head of the firm’s pharmaceutical division, told ...